Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy® Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. MicroStrategy Incorporated...
You must be a Standard 1 Year member to access this content.
Aird & Berlis LLP represented BZAM on the matter. On January 8, 2024, BZAM Ltd. (“BZAM”), a leading Canadian cannabis producer, completed the acquisition of Final...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advided the dealer manager and solicitation agent on the deal. Indie Semiconductor (NASDAQ: INDI) (the “Company”) announced it has completed its exchange offer...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Trinity Industries, Inc. in the offering. Trinity Industries, Inc. (NYSE: TRN) (“Trinity” or the “Company”) announced its Rule 144A / Regulation S...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Intercept Pharmaceuticals on the offering, and Davis Polk advised the sales agent involved. Intercept Pharmaceuticals, Inc. announced the SEC-registered at-the-market offering of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented AMD, while Davis Polk advised the representatives of the several underwriters in the offering. AMD (NASDAQ: AMD) has priced an underwritten public offering...
You must be a Standard 1 Year member to access this content.
